1. Therapy S, Resection L. Hepatocellular carcinoma (liver cancer) therapy. Johns Hopkins; 2012. pp. 2-9.

2. Dufour JF, Greten TF, Raymond E, Roskams T, De T, et al. Clinical practice guidelines EASL - EORTC clinical practice guidelines: management of hepatocellular carcinoma European organisation for research and treatment of cancer. J Hepatol 2012;56:908-43.

3. Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, et al. Is portal hypertension a contraindication to hepatic resection? Ann Surg 2009;250:922-8.

4. Anna Elisabetta Brunetti S, Francesco Fiore Gennaro Daniele Radiologia Interventistica -Istituto Nazionale Tumori E, Pascale F, Sperimentazioni cliniche -Istituto Nazionale Tumori -Napoli, Giuseppe Cabibbo -Napoli, Casadei Gardini A, et al. Coordinatore Bruno Daniele UOC Oncologia-Ospedale del Mare-Napoli. 2018. Available from:

5. Zhang ZQ, Xiong L, Zhou JJ, Miao XY, Li QL, et al. Ability of the ALBI grade to predict posthepatectomy liver failure and long-term survival after liver resection for different BCLC stages of HCC 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis. World J Surg Oncol 2018;16.

6. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, et al. The “50-50 Criteria” on postoperative day 5 an accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005;242:824-9.

7. Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, et al. Posthepatectomy liver failure: a definition and grading by the international study group of liver surgery (ISGLS). Surgery 2011;149:713-24.

8. Wang YY, Zhao XH, Ma L, Ye JZ, Wu FX, et al. Comparison of the ability of Child-Pugh score, MELD score, and ICG-R15 to assess preoperative hepatic functional reserve in patients with hepatocellular carcinoma. J Surg Oncol 2018;118:440-5.

9. Schneider PD. Preoperative assessment of liver function. Surg Clin North Am 2004;84:355-73.

10. Bosch J, Abraldes JG, Berzigotti A, García-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009;6:573-82.

11. Cucchetti A, Cescon M, Colecchia A, Neri F, Cappelli A, et al. Adding liver stiffness measurement to the routine evaluation of hepatocellular carcinoma resectability can optimize clinical outcome. Eur J Ultrasound 2017;38:515-22.

12. Peng W, Li JW, Zhang XY, Li C, Wen TF, et al. A novel model for predicting posthepatectomy liver failure in patients with hepatocellular carcinoma. PLoS One 2019;14:e0219219.

13. Cucchetti A, Cescon M, Golfieri R, Piscaglia F, Renzulli M, et al. Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma. J Hepatol 2016;64:79-86.

14. Zhang ZQ, Xiong L, Zhou JJ, Miao XY, Li QL, et al. Ability of the ALBI grade to predict posthepatectomy liver failure and long-term survival after liver resection for different BCLC stages of HCC. World J Surg Oncol 2018;16:208.

15. Phan K, An VVG, Ha H, Phan S, Lam V, et al. Hepatic resection for malignant liver tumours in the elderly: a systematic review and meta-analysis. ANZ J Surg 2015;85:815-22.

16. Tanaka S, Ueno M, Iida H, Kaibori M, Nomi T, et al. Preoperative assessment of frailty predicts age-related events after hepatic resection: a prospective multicenter study. J Hepatobiliary Pancreat Sci 2018;25:377-87.

17. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006;43:1317-25.

18. Mallet V, Dhalluin-Venier V, Roussin C, Bourliere M, Pettinelli ME, et al. The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B. Aliment Pharmacol Ther 2009;29:409-15.

19. Kim BK, Kim DY, Park JY, Ahn SH, Chon CY, et al. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients. Liver Int 2010;30:546-53.

20. Wang H, Liu A, Bo W, Feng X, Hu Y, et al. Fibrosis-4 model influences results of patients with hepatocellular carcinoma undergoing hepatectomy. Biomed Res Int 2018;2018.

21. Toyoda H, Kumada T, Tada T, Kaneoka Y, Maeda A. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection. Surgery 2015;157:699-707.

22. Dong J, Zhang XF, Zhu Y, Ma F, Liu C, et al. The value of the combination of fibrosis index based on the four factors and future liver remnant volume ratios as a predictor on posthepatectomy outcomes. J Gastrointest Surg 2015;19:682-91.

23. Zhou P, Chen B, Miao XY, Zhou JJ, Xiong L, et al. Comparison of FIB-4 index and child-pugh score in predicting the outcome of hepatic resection for hepatocellular carcinoma. J Gastrointest Surg 2019:10-3.

24. Zhang ZQ, Yang B, Zou H, Xiong L, Miao XY, et al. ALBI/ST ratio versus FIB-4 and APRI as a predictor of posthepatectomy liver failure in hepatocellular carcinoma patients. Medicine (Baltimore) 2019;98:e15168.

25. Lok ASF, Ghany MG, Goodman ZD, Wright EC, Everson GT, et al. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology 2005;42:282-92.

26. Ma J, Jiang Y, Gong G. Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection. Eur J Gastroenterol Hepatol 2013;25:428-34.

27. Zhou H, Long J, Hu H, Tian CY, Lin SD. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria. World J Gastroenterol 2019;25:5323-33.

28. Mobarak L, Omran D, Nabeel MM, Zakaria Z. Fibro markers for prediction of hepatocellular carcinoma in Egyptian patients with chronic liver disease. J Med Virol 2017;89:1062-8.

29. Forns X, Ampurdanès S, Llovet JM, Aponte J, Quintó L, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002;36:986-92.

30. Bourliere M, Penaranda G, Renou C, Botta-Fridlund D, Tran A, et al. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies. J Viral Hepat 2006;13:659-70.

31. Choi WM, Lee JH, Ahn H, Cho H, Cho YY, et al. Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection. Liver Int 2015;35:1992-2000.

32. Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol 2015;33:550-8.

33. Wang J, Zhang Z, Yan X, Li M, Xia J, et al. Albumin-Bilirubin (ALBI) as an accurate and simple prognostic score for chronic hepatitis B-related liver cirrhosis. Dig Liver Dis 2019;51:1172-8.

34. Wan SZ, Nie Y, Zhang Y, Liu C, Zhu X. Assessing the prognostic performance of the Child-Pugh, model for end-stage liver disease, and albumin-bilirubin scores in patients with decompensated cirrhosis: a large asian cohort from gastroenterology department. Dis Markers 2020;2020:5193028.

35. Zou D, Qi X, Zhu C, Ning Z, Hou F, et al. Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: a retrospective study. Turkish J Gastroenterol 2016;27:180-6.

36. Xu YX, Wang YB, Tan YL, Xi C, Xu XZ. Prognostic value of pretreatment albumin to bilirubin ratio in patients with hepatocellular cancer: a meta-analysis. Medicine (Baltimore) 2019;98:e14027.

37. Zou H, Yang X, Li QL, Zhou QX, Xiong L, et al. A comparative study of albumin-bilirubin score with Child-Pugh score, model for end-stage liver disease score and indocyanine green R15 in predicting posthepatectomy liver failure for hepatocellular carcinoma patients. Dig Dis 2018;36:236-43.

38. Toyoda H, Lai PBS, O’Beirne J, Chong CC, Berhane S, et al. Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade. Br J Cancer 2016;114:744-50.

39. Wang YY, Zhong JH, Su ZY, Huang JF, Lu SD, et al. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma. Br J Surg 2016;103:725-34.

40. Ke M, Xu T, Li N, Ren Y, Shi A, et al. Prognostic nutritional index predicts short-term outcomes after liver resection for hepatocellular carcinoma within the Milan criteria. Oncotarget 2016;7:81611-20.

41. Andreatos N, Amini N, Gani F, Margonis GA, Sasaki K, et al. Albumin-bilirubin score: predicting short-term outcomes including bile leak and post-hepatectomy liver failure following hepatic resection. J Gastrointest Surg 2017;21:238-48.

42. Li MX, Zhao H, Bi XY, Li ZY, Huang Z, et al. Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma: validation in a chinese cohort. Hepatol Res 2017;47:731-41.

43. Russolillo N, Forchino F, Conci S, Mele C, Langella S, et al. Validation of the albumin-indocyanine green evaluation model in patients with resected hepatocellular carcinoma and comparison with the albumin-bilirubin score. J Hepatobiliary Pancreat Sci 2019;26:51-7.

44. Božin T, Mustapić S, Bokun T, Patrlj L, Rakić M, et al. Albi score as a predictor of survival in patients with compensated cirrhosis resected for hepatocellular carcinoma: exploratory evaluation in relationship to palbi and meld liver function scores. Acta Clin Croat 2018;57:292-300.

45. Mai RY, Wang YY, Bai T, Chen J, Xiang BD, et al. Combination of ALBI and APRI to predict posthepatectomy liver failure after liver resection for HBV-related HCC patients. Cancer Manag Res 2019;11:8799-806.

46. De Gasperi A, Mazza E, Prosperi M. Indocyanine green kinetics to assess liver function: ready for a clinical dynamic assessment in major liver surgery? World J Hepatol 2016;8:355-67.

47. Levesque E, Martin E, Dudau D, Lim C, Dhonneur G, et al. Current use and perspective of indocyanine green clearance in liver diseases. Anaesth Crit Care Pain Med 2016;35:49-57.

48. Lisotti A, Azzaroli F, Buonfiglioli F, Montagnani M, Cecinato P, et al. Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. Hepatology 2014;59:643-50.

49. Kim HJ, Kim CY, Park EK, Hur YH, Koh YS, et al. Volumetric analysis and indocyanine green retention rate at 15 min as predictors of post-hepatectomy liver failure. HPB 2015;17:159-67.

50. Cheung TT, Chan SC, Chok KSH, Chan ACY, Yu WC, et al. Rapid measurement of indocyanine green retention by pulse spectrophotometry: a validation study in 70 patients with Child-Pugh A cirrhosis before hepatectomy for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2012;11:267-71.

51. Purcell R, Kruger P, Jones M. Indocyanine green elimination: a comparison of the LiMON and serial blood sampling methods. ANZ J Surg 2006;76:75-7.

52. Lisotti A, Azzaroli F, Cucchetti A, Buonfiglioli F, Cecinato P, et al. Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension. Liver Int 2016;36:1313-21.

53. Zipprich A, Kuss O, Rogowski S, Kleber G, Lotterer E, et al. Incorporating indocyanin green clearance into the model for end stage liver disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis. Gut 2010;59:963-8.

54. Marie-louise L Pind; FBTKSM. Indocyanine green retention test (icg-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis. Eur J Gastroenterol 2016;28:948-54.

55. Fan ST. Liver functional reserve estimation: state of the art and relevance for local treatments. J Hepatobiliary Pancreat Sci 2010;17:380-4.

56. Yau T, Tang VYF, Yao TJ, Fan ST, Lo CM, et al. Development of Hong Kong liver cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology 2014;146:1691-700.e3.

57. Lam CM, Fan ST, Lo CM, Wong J. Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg 1999;86:1012-7.

58. Lau H, Man K, Fan ST, Yu WC, Lo CM, et al. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 1997;84:1255-9.

59. Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 2005;12:16-22.

60. Kim JM, Kwon CHD, Joh JW, Park JB, Lee JH, et al. Can the model for end-stage liver disease score replace the indocyanine green clearance test in the selection of right hemihepatectomy in Child-Pugh class A? Ann Surg Treat Res 2014;86:122-9.

61. Au KP, Chan SC, Chok KSH, Chan ACY, Cheung TT, et al. Child-Pugh parameters and platelet count as an alternative to ICG test for assessing liver function for major hepatectomy. HPB Surg 2017;2017.

62. Fung J, Poon RTP, Yu WC, Chan SC, Chan ACY, et al. Use of liver stiffness measurement for liver resection surgery: correlation with indocyanine green clearance testing and post-operative outcome. PLoS One 2013;8.

63. Kitano S, Kim YI. ICG clearance in assessing cirrhotic patients with hepatocellular carcinoma for major hepatic resection. HPB Surg 1997;10:182-3.

64. Hsia CY, Lui WY, Chau GY, King KL, Loong CC, et al. Perioperative safety and prognosis in hepatocellular carcinoma patients with impaired liver function11No competing interests declared. J Am Coll Surg 2000;190:574-9.

65. Lao XM, Zhang YQ, Lin XJ, Guo RP, Chen MS, et al. Estimation of hepatic resection volume in hepatocellular carcinoma by ICG(R15) and its relation with postoperative liver failure. Ai Zheng 2005;24:337-40.

66. Hwang S, Ha TY, Song GW, Jung DH, Ahn CS, et al. Quantified risk assessment for major hepatectomy via the indocyanine green clearance rate and liver volumetry combined with standard liver volume. J Gastrointest Surg 2015;19:1305-14.

67. Kim DK, Choi JI, Choi MH, Park MY, Lee YJ, et al. Prediction of posthepatectomy liver failure: MRI with hepatocyte-specific contrast agent versus indocyanine green clearance test. AJR Am J Roentgenol 2018;211:580-7.

68. Wang L, Xie L, Zhang N, Zhu W, Zhou J, et al. Predictive value of intraoperative indocyanine green clearance measurement on postoperative liver function after anatomic major liver resection. J Gastrointest Surg 2019; doi: 10.1007/s11605-019-04262-5.

69. Giannini E, Botta F, Borro P, Risso D, Romagnoli P, et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 2003;52:1200-5.

70. Giannini EG, Zaman A, Kreil A, Floreani A, Dulbecco P, et al. Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol 2006;101:2511-9.

71. Ying L, Lin X, Xie ZL, Hu YP, Shi KQ. Performance of platelet count/spleen diameter ratio for diagnosis of esophageal varices in cirrhosis: a meta-analysis. Dig Dis Sci 2012;57:1672-81.

72. Ouyang GX, Zhang YM, Zhu SL, Wang P, Ren Y, et al. A novel, non-invasive model for diagnosing liver fibrosis stage in patients with hepatocellular carcinoma. Sci Rep 2018;8:13074.

73. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-26.

74. Mai RY, Ye JZ, Long ZR, Shi XM, Bai T, et al. Preoperative aspartate aminotransferase-to-platelet-ratio index as a predictor of posthepatectomy liver failure for resectable hepatocellular carcinoma. Cancer Manag Res 2019;11:1401-14.

75. Kim BK, Han KH, Park JY, Ahn SH, Kim JK, et al. A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis. Am J Gastroenterol 2010;105:1382-90.

76. Chon YE, Jung ES, Park JY, Kim DY, Ahn SH, et al. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B. J Clin Gastroenterol 2012;46:518-25.

77. Marasco G, Colecchia A, Dajti E, Ravaioli F, Cucchetti A, et al. Prediction of posthepatectomy liver failure: role of SSM and LSPS. J Surg Oncol 2019;119:400-1.

78. Peng Y, Qi X, Guo X. Child-pugh versus MELD score for the assessment of prognosis in liver cirrhosis a systematic review and meta-analysis of observational studies. Medicine (Baltimore) 2016;95:e2877.

79. Castera L. Non-invasive tests for liver fibrosis progression and regression. J Hepatol 2016;64:232-3.

80. de Franchis R, Baveno VI Faculty. Expanding consensus in portal hypertension: report of the baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 2015;63:743-52.

81. Colecchia A, Ravaioli F, Marasco G, Colli A, Dajti E, et al. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease. J Hepatol 2018;69:308-17.

82. Singh S, Fujii LL, Murad MH, Wang Z, Asrani SK, et al. Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2013;11:1573-84.e1-2. quiz e88-9

83. Kim SU, Ahn SH, Park JY, Kim DY, Chon CY, et al. Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan®) before curative resection of hepatocellular carcinoma: a pilot study. Hepatol Int 2008;2:471-7.

84. Cescon M, Colecchia A, Cucchetti A, Peri E, Montrone L, et al. Value of transient elastography measured with fibroscan in predicting the outcome of hepatic resection for hepatocellular carcinoma. Ann Surg 2012;256:706-13.

85. Harada N, Shirabe K, Ijichi H, Matono R, Uchiyama H, et al. Acoustic radiation force impulse imaging predicts postoperative ascites resulting from curative hepatic resection for hepatocellular carcinoma. Surgery 2012;151:837-43.

86. Wong JSW, Wong GLH, Chan AWH, Wong VWS, Cheung YS, et al. Liver stiffness measurement by transient elastography as a predictor on posthepatectomy outcomes. Ann Surg 2013;257:922-8.

87. Zhang ZM, Zhang YM, Yao F, Yi P, Huang S, et al. Analysis on postoperative efficacy of radical hepatectomy for patients with Non-HBV/HCV hepatocellular carcinoma. Asian Pac J Cancer Prev 2015;16:3479-83.

88. Nishio T, Taura K, Koyama Y, Tanabe K, Yamamoto G, et al. Prediction of posthepatectomy liver failure based on liver stiffness measurement in patients with hepatocellular carcinoma. Surgery 2016;159:399-408.

89. Chong CCN, Wong GLH, Chan AWH, Wong VWS, Fong AK, et al. Liver stiffness measurement predicts high-grade post-hepatectomy liver failure: a prospective cohort study. J Gastroenterol Hepatol 2017;32:506-14.

90. Han H, Yang J, Zhuge Y, Zhang M, Wu M. Point shear wave elastography to evaluate and monitor changing portal venous pressure in patients with decompensated cirrhosis. Ultrasound Med Biol 2017;43:1134-40.

91. Abe H, Midorikawa Y, Mitsuka Y, Aramaki O, Higaki T, et al. Predicting postoperative outcomes of liver resection by magnetic resonance elastography. Surgery 2017;162:248-55.

92. Shen Y, Zhou C, Zhu G, Shi G, Zhu X, et al. Liver stiffness assessed by shear wave elastography predicts postoperative liver failure in patients with hepatocellular carcinoma. J Gastrointest Surg 2017;21:1471-9.

93. Rajakannu M, Cherqui D, Ciacio O, Golse N, Pittau G, et al. Liver stiffness measurement by transient elastography predicts late posthepatectomy outcomes in patients undergoing resection for hepatocellular carcinoma. Surgery 2017;162:766-74.

94. Donadon M, Fontana A, Palmisano A, Viganò L, Procopio F, et al. Individualized risk estimation for postoperative morbidity after hepatectomy: the Humanitas score. HPB 2017;19:910-8.

95. Wu D, Chen E, Liang T, Wang M, Chen B, et al. Predicting the risk of postoperative liver failure and overall survival using liver and spleen stiffness measurements in patients with hepatocellular carcinoma. Medicine (Baltimore) 2017;96:e7864.

96. Lei J, Ji X, Hong J, Li W, Chen Y, et al. Prediction of posthepatectomy liver failure using transient elastography in patients with hepatitis B related hepatocellular carcinoma. BMC Gastroenterol 2017;17:171.

97. Hu H, Han H, Han XK, Wang WP, Ding H. Nomogram for individualised prediction of liver failure risk after hepatectomy in patients with resectable hepatocellular carcinoma: the evidence from ultrasound data. Eur Radiol 2018;28:877-85.

98. Sato N, Kenjo A, Kimura T, Okada R, Ishigame T, et al. Prediction of major complications after hepatectomy using liver stiffness values determined by magnetic resonance elastography. Br J Surg 2018;105:1192-9.

99. Procopet B, Fischer P, Horhat A, Mois E, Stefanescu H, et al. Good performance of liver stiffness measurement in the prediction of postoperative hepatic decompensation in patients with cirrhosis complicated with hepatocellular carcinoma. Med Ultrason 2018;20:272.

100. Huang Z, Huang J, Zhou T, Cao H, Tan B. Prognostic value of liver stiffness measurement for the liver-related surgical outcomes of patients under hepatic resection: a meta-analysis. PLoS One 2018;13:e0190512.

101. Ma X, Wang L, Wu H, Feng Y, Han X, et al. Spleen stiffness is superior to liver stiffness for predicting esophageal varices in chronic liver disease: a meta-analysis. PLoS One 2016;11:e0165786.

102. Galle PR, Forner A, Llovet JM, Mazzaferro V, Piscaglia F, et al. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2018;69:182-236.

103. Longbotham D, Young A, Nana G, Feltbower R, Hidalgo E, et al. The impact of age on post-operative liver function following right hepatectomy: a retrospective, single centre experience. HPB (Oxford) 2020;22:151-60.

104. Şirli R, Sporea I, Bota S, Jurchiş A. Factors influencing reliability of liver stiffness measurements using transient elastography (M-probe) - Monocentric experience. Eur J Radiol 2013;82:e313-6.

105. Varbobitis IC, Siakavellas SI, Koutsounas IS, Karagiannakis DS, Ioannidou P, et al. Reliability and applicability of two-dimensional shear-wave elastography for the evaluation of liver stiffness. Eur J Gastroenterol Hepatol 2016;28:1204-9.

106. D’Onofrio M, De Robertis R, Demozzi E, Crosara S, Canestrini S, et al. Liver volumetry: is imaging reliable? Personal experience and review of the literature. World J Radiol 2014;6:62-71.

107. Cescon M, Cucchetti A, Grazi GL, Ferrero A, Viganò L, et al. Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables. Arch Surg 2009;144:57-63. discussion 63

108. Shoup M. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 2003;7:325-30.

109. Kim HJ, Kim CY, Hur YH, Koh YS, Kim JC, et al. Comparison of remnant to total functional liver volume ratio and remnant to standard liver volume ratio as a predictor of postoperative liver function after liver resection. Korean J Hepato-Biliary-Pancreatic Surg 2013;17:143.

110. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239:818-25. discussion 825-7

111. Vauthey JN, Abdalla EK, Doherty DA, Gertsch P, Fenstermacher MJ, et al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl 2002;8:233-40.

112. Kishi Y, Abdalla EK, Chun YS, Zorzi D, Madoff DC, et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg 2009;250:540-8.

113. Schindl MJ, Redhead DN, Fearon KCH, Garden OJ, Wigmore SJ, et al. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 2005;54:289-96.

114. Chuang YH, Ou HY, Lazo MZ, Chen CL, Chen MH, et al. Predicting post-hepatectomy liver failure by combined volumetric, functional MR image and laboratory analysis. Liver Int 2018;38:868-74.

115. Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, et al. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 2007;94:1386-94.

116. Guglielmi A, Ruzzenente A, Conci S, Valdegamberi A, Iacono C. How much remnant is enough in liver resection? Dig Surg 2012;29:6-17.

117. Kauffmann R, Fong Y. Post-hepatectomy liver failure. Hepatobiliary Surg Nutr 2014;3:238-46.

118. Reddy SK, Marsh JW, Varley PR, Mock BK, Chopra KB, et al. Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: a case-control study. Hepatology 2012;56:2221-30.

119. Kaido T, Hamaguchi Y, Uemoto S. Significance of preoperative sarcopenia to liver surgery. HepatoBiliary Surg Nutr 2019;8:59-62.

120. Valero V, Amini N, Spolverato G, Weiss MJ, Hirose K, et al. Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumors. J Gastrointest Surg 2015;19:272-81.

121. Peng PD, Van Vledder MG, Tsai S, De Jong MC, Makary M, et al. Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB 2011;13:439-46.

122. Toshikuni N, Arisawa T, Tsutsumi M. Nutrition and exercise in the management of liver cirrhosis. World J Gastroenterol 2014;20:7286-97.

123. Maharshi S, Sharma BC, Srivastava S. Malnutrition in cirrhosis increases morbidity and mortality. J Gastroenterol Hepatol 2015;30:1507-13.

124. Buchard B, Boirie Y, Cassagnes L, Lamblin G, Coilly A, et al. Assessment of malnutrition, sarcopenia and frailty in patients with cirrhosis: which tools should we use in clinical practice? Nutrients 2020;12.

125. Sinclair M, Gow PJ, Grossmann M, Angus PW. Review article: Sarcopenia in cirrhosis - Aetiology, implications and potential therapeutic interventions. Aliment Pharmacol Ther 2016;43:765-77.

126. Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014;15:95-101.

127. Harimoto N, Shirabe K, Yamashita YI, Ikegami T, Yoshizumi T, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg 2013;100:1523-30.

128. Voron T, Tselikas L, Pietrasz D, Pigneur F, Laurent A, et al. Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg 2015;261:1173-83.

129. Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, et al. Preoperative visceral adiposity and muscularity predict poor outcomes after hepatectomy for hepatocellular carcinoma. Liver Cancer 2019;8:92-109.

130. Dello SAWG, Lodewick TM, Van Dam RM, Reisinger KW, Van Den Broek MAJ, et al. Sarcopenia negatively affects preoperative total functional liver volume in patients undergoing liver resection. HPB 2013;15:165-9.

131. Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, et al. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care 2008;11:693-700.

132. Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Fujimoto Y, et al. Muscle steatosis is an independent predictor of postoperative complications in patients with hepatocellular carcinoma. World J Surg 2016;40:1959-68.

133. Sharma P, Parikh ND, Yu J, Barman P, Derstine BA, et al. Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients. Liver Transplant 2016;22:1092-8.

134. Miyachi Y, Kaido T, Yao S, Shirai H, Kobayashi A, et al. Bone mineral density as a risk factor for patients undergoing surgery for hepatocellular carcinoma. World J Surg 2019;43:920-8.

135. Shen YN, Zheng ML, Guo CX, Bai XL, Pan Y, et al. The role of imaging in prediction of post-hepatectomy liver failure. Clin Imaging 2018;52:137-45.

136. Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 2003;226:71-8.

137. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol 1998;170:397-402.

138. Tamada T, Ito K, Higaki A, Yoshida K, Kanki A, et al. Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers. Eur J Radiol 2011;80:e311-6.

139. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, et al. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992;183:59-64.

140. Frericks BB, Loddenkemper C, Huppertz A, Valdeig S, Stroux A, et al. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA. AJR Am J Roentgenol 2009;193:1053-60.

141. Kukuk GM, Schaefer SG, Fimmers R, Hadizadeh DR, Ezziddin S, et al. Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests. Eur Radiol 2014;24:2482-90.

142. Watanabe H, Kanematsu M, Goshima S, Kondo H, Onozuka M, et al. Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations. Radiology 2011;259:142-50.

143. Wibmer A, Prusa AM, Nolz R, Gruenberger T, Schindl M, et al. Liver failure after major liver resection: risk assessment by using preoperative gadoxetic acid-enhanced 3-T MR imaging. Radiology 2013;269:777-86.

144. Jin YJ, Lee SH, Cho SG, Kim JH, Lee JW, et al. Prediction of postoperative liver failure using gadoxetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 2016;31:1349-56.

145. Theilig D, Steffen I, Malinowski M, Stockmann M, Seehofer D, et al. Predicting liver failure after extended right hepatectomy following right portal vein embolization with gadoxetic acid-enhanced MRI. Eur Radiol 2019;29:5861-72.

146. Asenbaum U, Kaczirek K, Ba-Ssalamah A, Ringl H, Schwarz C, et al. Post-hepatectomy liver failure after major hepatic surgery: not only size matters. Eur Radiol 2018;28:4748-56.

147. Hoekstra LT, de Graaf W, Nibourg GAA, Heger M, Bennink RJ, et al. Physiological and biochemical basis of clinical liver function tests: a review. Ann Surg 2013;257:27-36.

148. Iimuro Y, Kashiwagi T, Yamanaka J, Hirano T, Saito S, et al. Preoperative estimation of asialoglycoprotein receptor expression in the remnant liver from CT/99m Tc-GSA SPECT fusion images correlates well with postoperative liver function parameters. J Hepatobiliary Pancreat Sci 2010;17:673-81.

149. Okabayashi T, Shima Y, Morita S, Shimada Y, Sumiyoshi T, et al. Liver Function assessment using technetium 99m-galactosyl single-photon emission computed tomography/CT Fusion imaging: a prospective trial. J Am Coll Surg 2017;225:789-97.

150. May BJ, Madoff DC. Portal vein embolization: rationale, technique, and current application. Semin Intervent Radiol 2012;29:81-9.

151. Capussotti L, Muratore A, Baracchi F, Lelong B, Ferrero A, et al. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases. Arch Surg 2008;143:978-82. discussion 982

152. Ray S, Mehta NN, Golhar A, Nundy S. Post hepatectomy liver failure - a comprehensive review of current concepts and controversies. Ann Med Surg 2018;34:4-10.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)


All published articles are preserved here permanently:


All published articles are preserved here permanently: